TRS-007

N/A

Report date: 2022/01/05 15:24:33

Base Information

Drug NameTRS-007
Drug Alias NameTRS-007
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment > Single-domain antibody (Nanobody)
Mechanisms of ActionProgrammed cell death protein 1 blockers
TargetsSynuclein alpha
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesZhejiang Teruisi Pharmaceutical Inc
China Registration ClassN/A

Develop Information

Active CompaniesZhejiang Teruisi Pharmaceutical Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A